NCT01370928

Brief Summary

The purpose of this study is to compare the performance of a new prototype colonoscope with a standard colonoscope used world-wide today. The prototype colonoscope is more flaccid with a smaller diameter than the standard colonoscope. The hypothesis to be tested is that the prototype will improve negotiation of sharp bends and inflict less discomfort or pain to the patient. Both colonoscopes are manufactured by the same company.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
190

participants targeted

Target at below P25 for phase_3 colorectal-cancer

Timeline
Completed

Started Mar 2011

Shorter than P25 for phase_3 colorectal-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

March 21, 2011

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 10, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
Last Updated

April 27, 2012

Status Verified

April 1, 2012

Enrollment Period

3 months

First QC Date

March 21, 2011

Last Update Submit

April 26, 2012

Conditions

Keywords

Colonoscopy performancePainDiscomfortScreeningColorectal cancerColorectal cancer screening, diagnostics of adenomas

Outcome Measures

Primary Outcomes (1)

  • Patients´ evaluation of pain and discomfort

    Analysis of validated feed-back questionnaires to be filled in on the day after the proceudre by the trial participants.

    24 hours

Secondary Outcomes (4)

  • Time used to reach the caecum

    1 hour

  • Need for sedation/analgesics during the colonoscopy procedure

    1 hour

  • Need to change to a different colonoscope to complete the procedure

    10 minutes

  • Caecum intubation rate

    30 minutes

Study Arms (2)

Prototype colonoscope

EXPERIMENTAL

The new colonoscope to be tested

Device: Olympus PCF-Y0014-L

Standard colonoscope

ACTIVE COMPARATOR

The standard colonoscope used world-wide today.

Device: Standard colonoscope

Interventions

Screening colonoscopy with a prototype colonoscope

Also known as: Olympus PCF-Y0014-L colonoscope
Prototype colonoscope

Screening colonoscopy

Also known as: Olympus series 160 colonoscope
Standard colonoscope

Eligibility Criteria

Age54 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • For information about the NordICC trial see clinicaltrials.gov NCT00883792

You may not qualify if:

  • Pregnancy
  • Persons younger than 18 years
  • Persons unable to comprehend the information given
  • not possible to start the examination without prior administration of sedation/analgesics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sørlandet Sykehus HF

Kristiansand, 4604, Norway

Location

Related Publications (1)

  • Garborg KK, Loberg M, Matre J, Holme O, Kalager M, Hoff G, Bretthauer M. Reduced pain during screening colonoscopy with an ultrathin colonoscope: a randomized controlled trial. Endoscopy. 2012 Aug;44(8):740-6. doi: 10.1055/s-0032-1309755. Epub 2012 May 23.

MeSH Terms

Conditions

Colorectal NeoplasmsAdenomaPain

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Bretthauer, MD, Ph.d.

    Oslo University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2011

First Posted

June 10, 2011

Study Start

March 1, 2011

Primary Completion

June 1, 2011

Study Completion

August 1, 2011

Last Updated

April 27, 2012

Record last verified: 2012-04

Locations